UnitedHealth Group Inc. buy Royal Bank of Canada
Start price
30.11.23
/
50%
€501.00
Target price
30.11.24
€546.23
Performance (%)
-7.29%
Price
12:32
€461.05
Summary
This prediction is currently active. With a performance of -7.29%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. Dividends of €3.45 are taken into consideration when calculating the performance. This prediction currently runs until 30.11.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
UnitedHealth Group Inc. | -1.573% | -1.573% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread UnitedHealth Group Inc. diskutieren
UnitedHealth Group Incorporated (NYSE: UNH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $596.00 price target on the stock.
Ratings data for UNH provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for UnitedHealth Group Inc.
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€456.50
29.02.24
29.02.24
€551.42
28.02.25
28.02.25
1.87%
12:32
12:32
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€480.00
16.01.24
16.01.24
€547.55
16.01.25
16.01.25
-3.12%
12:32
12:32
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€510.00
16.10.23
16.10.23
€564.11
16.10.24
16.10.24
-8.48%
12:32
12:32
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€461.00
17.04.23
17.04.23
€542.27
17.04.24
17.04.24
-2.12%
18.04.24
18.04.24